Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

299

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

October 31, 2008

Study Completion Date

April 30, 2009

Conditions
Parkinson's Disease
Interventions
DEVICE

Bilateral Deep Brain Stimulation

The DBS site (STN or GPi) was assigned on a random basis at the time the patient enters the surgical phase of the trial.

Trial Locations (14)

19104

University of Pennsylvania Hospital, Philadelphia

19106

Philadelphia, OPC, Philadelphia

23249

Hunter Holmes McGuire VA Medical Center, Richmond

Medical College of Virginia, Richmond

77030

Baylor College of Medicine, Houston

Michael E. DeBakey VA Medical Center (152), Houston

90073

University of California at Los Angeles, Los Angeles

VA Greater Los Angeles Healthcare System, West LA, West Los Angeles

94121

University of California at San Francisco, San Francisco

VA Medical Center, San Francisco, San Francisco

97201

VA Medical Center, Portland, Portland

97207

Oregon Health Sciences University, Portland

98108

VA Puget Sound Health Care System, Seattle, Seattle

52246-2208

VA Medical Center, Iowa City, Iowa City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Medtronic

INDUSTRY

lead

US Department of Veterans Affairs

FED

NCT01076452 - Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial | Biotech Hunter | Biotech Hunter